Call for Applications📢! Are you a recent graduate passionate about health and research? Apply for the fully funded PGD studentship offered by IDeAL, Africa & Pwani University and gain knowledge and practical research experience. 🔗: shorturl.at/TqKHI 🗓️: July 20, 2025

Is there anything more annoying than buzzing mosquitoes at night? 🦟Yes! Mosquitoes and beg bugs! Our new study shows that ivermectin at clinically relevant blood levels not only kills malaria mosquitoes, but also bed bugs 💀 parasitesandvectors.biomedcentral.com/articles/10.11…

Today we held a one-day Malaria Policy Engagement meeting that gathered researchers, national policymakers and county health leaders from Kilifi, Kwale, and Mombasa counties. Organized under the EDCTP East African Consortium for Clinical Research (EACCR3) malaria work package,

Reminder! Still time to apply for the fully funded health research studentship by KEMRI-Wellcome Trust & Pwani University! Don't miss out! Deadline: July 20, 2025! Apply now: shorturl.at/TqKHI

Ivermectin to Control Malaria — A Cluster-Randomized Trial | New England Journal of Medicine nejm.org/doi/full/10.10…

Findings from a landmark study by KEMRI & Partners has shown that ivermectin, when administered through Mass Drug Administration (MDA), can reduce malaria transmission by 26%, offering a powerful complementary tool in the fight against #malaria 🔗kemri.go.ke/latest-press-r…

Scientists find that an old deworming drug can reduce malaria transmission when given in mass at the right time. #KEMRI_WELLCOME #ISGlobal #UNITAID nation.africa/kenya/health/s…

🚨We are hiring! : Early Post-Doctoral Mathematics Modeller🚨 Are you passionate about using mathematics to tackle real-world health challenges like antimicrobial resistance (AMR) and respiratory pathogens? KEMRI-Wellcome is recruiting an Early Post-Doctoral Mathematics

New study in Kenya shows that mass drug administration using ivermectin cuts new malaria infections by 26% among children aged 5–15, with no rise in serious side-effects. ~ A large trial at the coast of Kenya has shown that giving the antiparasitic drug IVERMECTIN to most

🚨Vaccinology Webinar alert🚨 What does it take to build trust in vaccine development? Join Noni Mumba, Head of Engagement, KEMRI-Wellcome as she shares insights on building community literacy around vaccines. 🗓️August, 7th 2025 🕚11:00AM–12:30PM GMT+3 🔗 shorturl.at/QkPVI

Exciting opportunity! Apply for the ProtEqt Voice PhD Studentship at KEMRI-Wellcome and help shape equitable, responsive Primary Health Care in Kenya & Tanzania. Stipend, Tuition, Insurance, & Research support provided. Deadline: Aug 25, 2025 Apply: shorturl.at/7E7Ds

🚨We are hiring : Assistant Research Officer- Genomics and Bioinformatics!🚨 Join our team and be part of research contributing to public health innovation. 📍 Kilifi, Kenya 🗓️ Sunday, August 24th, 2025 🔗 shorturl.at/Bgska

Call for Applications📢! Are you an African scientist passionate about vaccine development & bio manufacturing? Apply for a 3-month Apprenticeship in Egypt with KEMRI-Wellcome and BIOGENERIC PHARMA . 📍Arab Republic of Egypt 🗓️29th August 2025 at 5pm 🔗 shorturl.at/FiFKF

Are you attending #TICAD9 in Yokohama? Come visit us at Stand Number 22 Hall B,C of Pacifico to discuss how we can partner to advance healthcare innovation for Africa. So far, we've secured Kshs. 3 billion investment from our partners at MOL Logistics for our ongoing projects

Today is #WorldMosquitoDay. We reaffirm our commitment to advancing research, driving innovation, and empowering communities in the fight against malaria and other mosquito-borne diseases.

Our latest publication demonstrates how MALDI-TOF MS can accurately identify secondary malaria malaria vectors from Kenya and Mozambique. Performance was comparable to sequencing but costing less than 0.2 USD/sample. Congrats to Mercy Tuwei and team! malariajournal.biomedcentral.com/articles/10.11…

This study, by colleagues KEMRI-Wellcome , demonstrates the potential of MALDI-TOF MS as a cost-effective, scalable, and accurate tool for mosquito species identification. A key highlight is that the method is 91% accurate in species identification, validated by sequencing, and

Great article on our research on MALDI-TOF MS for mosquito typing. Understanding the threat is integral to supporting decision-makers in developing tailored control strategies, enhancing the country's preparedness to control mosquito-borne diseases. healthbusiness.co.ke/9349/kemri-wel…

Congratulations Professor Edwine Barasa, appointed Executive Director of the KEMRI-Wellcome Research Programme KEMRI-Wellcome Read more 👉 tropicalmedicine.ox.ac.uk/news/professor…